FR2987559B1 - Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile - Google Patents

Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile Download PDF

Info

Publication number
FR2987559B1
FR2987559B1 FR1200646A FR1200646A FR2987559B1 FR 2987559 B1 FR2987559 B1 FR 2987559B1 FR 1200646 A FR1200646 A FR 1200646A FR 1200646 A FR1200646 A FR 1200646A FR 2987559 B1 FR2987559 B1 FR 2987559B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
compositions based
ferrous salt
relates
new pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1200646A
Other languages
English (en)
Other versions
FR2987559A1 (fr
Inventor
Georges Bernard Carp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRE X.O, FR
Original Assignee
LABORATOIRES LISAPHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATOIRES LISAPHARM filed Critical LABORATOIRES LISAPHARM
Priority to FR1200646A priority Critical patent/FR2987559B1/fr
Publication of FR2987559A1 publication Critical patent/FR2987559A1/fr
Application granted granted Critical
Publication of FR2987559B1 publication Critical patent/FR2987559B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention se rapporte au domaine des nécessités de la vie et plus particulièrement au domaine de la pharmacie galénique. L'invention concerne plus spécifiquement des compositions pharmaceutiques antianémiques destinées à l'administration orale à base d'un complexe de succinate ferreux et d'acide succinique présentées sous un conditionnement unitaire, en mélange ou en association avec un agent diluant, un agent de mise en suspension et un édulcorant de synthèse. L'invention concerne également l'utilisation de telles compositions comme médicament de l'anémie résultant d'une carence martiale.
FR1200646A 2012-03-01 2012-03-01 Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile Active FR2987559B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1200646A FR2987559B1 (fr) 2012-03-01 2012-03-01 Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1200646A FR2987559B1 (fr) 2012-03-01 2012-03-01 Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile
FR1200646 2012-03-01

Publications (2)

Publication Number Publication Date
FR2987559A1 FR2987559A1 (fr) 2013-09-06
FR2987559B1 true FR2987559B1 (fr) 2019-05-10

Family

ID=46650571

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1200646A Active FR2987559B1 (fr) 2012-03-01 2012-03-01 Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile

Country Status (1)

Country Link
FR (1) FR2987559B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210024056A (ko) * 2018-06-22 2021-03-04 엔진 바이오사이언스 리미티드 혈액 장애 치료를 위한 숙신산 및 유도체
CN116217384A (zh) * 2023-03-17 2023-06-06 金陵药业股份有限公司 一种琥珀酸亚铁碱式盐晶型、制备方法以及组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670344A (en) * 1996-02-02 1997-09-23 The Procter & Gamble Company Preventing undesired color formation in iron fortified chocolate-flavored beverages by including edible acids or their salts

Also Published As

Publication number Publication date
FR2987559A1 (fr) 2013-09-06

Similar Documents

Publication Publication Date Title
WO2005115406A3 (fr) 8-(2-hydroxyphenoxy)octyldiethanolamine et ses sels utile dans l'administration d'agents actifs
MA34727B1 (fr) Imidazolylimidazoles condensés utilisés comme composés antiviraux
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
MA34765B1 (fr) Antagonistes des récepteurs de l'acide lysophosphatidique et utilisations de ceux-ci
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
SG10201804552WA (en) Nanoparticle compositions, formulations thereof, and uses therefor
TW200800931A (en) Novel piperazines as antimalarial agents
MA34067B1 (fr) Composés à base de complexes de fe(iii) pour le traitement et la prévention des carences en fer et des anémies dues à une carence en fer
TR200806298A2 (tr) Farmasötik formülasyon
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
NO20073158L (no) Stabiliserte 99mTC-sammensetninger
MA37742B1 (fr) Dérivés d'oestra-1,3,5 (10), 16-tétraène substitués en position 3, leurs procédés de préparation, préparations pharmaceutiques les contenant, et leur utilisation pour la fabrication de médicaments
IN2014DN08870A (fr)
MA33679B1 (fr) Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole
EA201591188A1 (ru) Доставка глатирамера ацетата через слизистую оболочку
MA38679A1 (fr) Modulateurs du récepteur de cxcr7
FR2984750B1 (fr) Nouvelles compositions pharmaceutiques comprenant un anticorps liant le recepteur humain de l'hormone anti-mullerienne de type ii
MA41174B1 (fr) Dérivés d'imidazopyridazine utilisés en tant qu'inhibiteurs de pi3kbeta
FR2987559B1 (fr) Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile
MA34867B1 (fr) Nouvelle association entre le 4-{3-[c/s-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un antigoniste des recepteurs nmda et les compositions pharmaceutiques qui la contiennent
MY160904A (en) Piperazines as antimalarial agents
ATE390121T1 (de) Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator
MA34977B1 (fr) Composés à base de complexes de FE(III) pour le traitement et la prévention de carences en fer et d'anémies dues à une carence en fer.
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

TP Transmission of property

Owner name: LABORATOIRE DE L'INOFER, FR

Effective date: 20151208

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

CA Change of address

Effective date: 20171019

TP Transmission of property

Owner name: LABORATOIRE X.O, FR

Effective date: 20181024

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13